Kunming Longjin Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.
002750SZSE
Announcement on the Appointment of the Lead Underwriter
✨ AI Summary
Kunming Longjin Pharmaceutical Co., Ltd. has appointed Southwest Securities Co., Ltd. as its lead underwriter following the decision by the Shenzhen Stock Exchange to terminate its stock listing. The company will transition its shares to the delisting board for trading. This appointment ensures that the shares can be transferred within 45 trading days after delisting. Further announcements regarding share registration and custody will be made.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.